Viewing StudyNCT00004227

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004227
Status: TERMINATED
Last Update Posted: 2014-02-06
First Post: 2000-01-28
Brief Title: Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx Hypopharynx or Larynx
Sponsor: University of Alabama at Birmingham
Organization: University of Alabama at Birmingham
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Head and Neck Cancer
Keywords:
Name View
recurrent squamous cell carcinoma of the larynx View
stage III squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the oropharynx View
recurrent squamous cell carcinoma of the oropharynx View
stage III squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the hypopharynx View
recurrent squamous cell carcinoma of the hypopharynx View
stage III squamous cell carcinoma of the larynx View
stage IV squamous cell carcinoma of the larynx View